Interdisciplinary Perspectives on Infectious Diseases / 2012 / Article / Tab 1

Review Article

Epidemiology of Rhodotorula: An Emerging Pathogen

Table 1

Summary of reports of Rhodotorula fungemia (2000–2011).

ReferenceNumber of described casesSpeciesUnderlying disease

[46]7R. mucilaginosa Hematological-solid malignancies
[52]10R.mucilaginosa SBD; LT; AIDS
[48]25R. mucilaginosa Hematological-solid malignancies; LC; SCA; SBD; CLD
[53]2R. glutinis/R. mucilaginosa Lymphoma; solid tumor
[54]1R. mucilaginosa Lymphoma
[55]1R. mucilaginosa Lymphoma
[56]2R. mucilaginosa Acute myeloid leukemia
[57]1R. glutinis Nasopharyngeal carcinoma
[58]1R. mucilaginosa SBD
[59]3Rhodotorula spp.Hematological-solid malignancies
[60]4R. mucilaginosa Prematurity
[61]1R. mucilaginosa Acute myeloid leukemia
[62]1R. mucilaginosa SCA
[63]2R. glutinis Broad spectrum antibiotics
[64]1R. glutinis Systemic lupus erythematous
[65]1R. glutinis Solid organ transplant
[66]1R. glutinis Liver cirrhosis
[67]1R. glutinis Acute lymphoid leukemia
[68]1R. mucilaginosa MS/BMT
[69]1R. mucilaginosa Multiple abdominal surgeries; ovarian cancer; bowel necrosis

BMT: bone marrow transplant; CLD: congenital liver disease; LC: liver cirrhosis; LT: lung transplant; MS: myelodysplastic syndrome; SBD: short bowel disease; SCA: sickle cell anemia; SOT: solid organ transplant.